z-logo
Premium
(2 E ,4 E )‐ N ‐(4‐(1 H ‐Indol‐3‐yl)piperidin‐1‐yl)alkyl‐5‐(substituted phenyl)‐2,4‐pentadienamides as Antiallergic Agents with Antihistaminic and Anti Slow‐Reacting Substance (SRS) Activities
Author(s) -
Shigenaga Shinji,
Manabe Takashi,
Matsuda Hiroshi,
Fujii Takashi,
Matsuo Masaaki
Publication year - 1996
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.19963290103
Subject(s) - chemistry , in vivo , conjugate , in vitro , histamine , stereochemistry , glucuronic acid , pharmacology , biochemistry , polysaccharide , medicine , mathematical analysis , microbiology and biotechnology , mathematics , biology
As an extension of our study aiming to discover a novel compound with dual activities against histamine and slow‐reacting substance (SRS), we synthesized two types of indolylpiperidine derivatives, 3 and 4–20. Testing for in vivo antianaphylactic activity and for in vitro anti‐SRS activity revealed that (2 E ,4 E )‐5‐(3,5‐dimethoxy‐4‐hydroxyphenyl)‐ N ‐(2‐(4‐(1 H ‐indol‐3‐yl)piperidin‐1‐yl)ethyl)‐2,4‐pentadienamide ( 11 ) exhibited potent dual activities with ED 50 = 0.89 mg/kg and IC 50 = 1.43 μM, respectively. However, the plasma concentration of unchanged 11 was very low when administered orally in guinea pigs. This result can be explained by fast formation of a glucuronic acid conjugate.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom